View in EDS HTML Full Text PDF Full Text

A Novel Prognostic Indicator for Immunotherapy Response: Lymphocyte-to-Albumin (LA) Ratio Predicts Survival in Metastatic NSCLC Patients.

Saved in:
Bibliographic Details
Title: A Novel Prognostic Indicator for Immunotherapy Response: Lymphocyte-to-Albumin (LA) Ratio Predicts Survival in Metastatic NSCLC Patients.
Authors: Yildirim S; Department of Medical Oncology, Kartal Dr. Lütfi Kirdar City Hospital, Health Science University, Istanbul 34865, Turkey., Dogan A; Department of Medical Oncology, Kartal Dr. Lütfi Kirdar City Hospital, Health Science University, Istanbul 34865, Turkey., Akdag G; Department of Medical Oncology, Kartal Dr. Lütfi Kirdar City Hospital, Health Science University, Istanbul 34865, Turkey., Cavdar E; Department of Medical Oncology, Faculty of Medicine, Tekirdag Namik Kemal University, Tekirdağ 59030, Turkey., Kinikoglu O; Department of Medical Oncology, Kartal Dr. Lütfi Kirdar City Hospital, Health Science University, Istanbul 34865, Turkey., Oksuz S; Department of Medical Oncology, Kartal Dr. Lütfi Kirdar City Hospital, Health Science University, Istanbul 34865, Turkey., Yildiz HS; Department of Medical Oncology, Kartal Dr. Lütfi Kirdar City Hospital, Health Science University, Istanbul 34865, Turkey., Kucukoz Uzun A; Department of Nuclear Medicine, Kartal Dr. Lütfi Kirdar City Hospital, Health Science University, Istanbul 34865, Turkey., Isik D; Department of Medical Oncology, Kartal Dr. Lütfi Kirdar City Hospital, Health Science University, Istanbul 34865, Turkey., Surmeli H; Department of Medical Oncology, Kartal Dr. Lütfi Kirdar City Hospital, Health Science University, Istanbul 34865, Turkey., Basoglu T; Department of Medical Oncology, Kartal Dr. Lütfi Kirdar City Hospital, Health Science University, Istanbul 34865, Turkey., Sever ON; Department of Medical Oncology, Kartal Dr. Lütfi Kirdar City Hospital, Health Science University, Istanbul 34865, Turkey., Odabas H; Department of Medical Oncology, Kartal Dr. Lütfi Kirdar City Hospital, Health Science University, Istanbul 34865, Turkey., Yildirim ME; Department of Medical Oncology, Kartal Dr. Lütfi Kirdar City Hospital, Health Science University, Istanbul 34865, Turkey., Turan N; Department of Medical Oncology, Kartal Dr. Lütfi Kirdar City Hospital, Health Science University, Istanbul 34865, Turkey.
Source: Cancers [Cancers (Basel)] 2024 Jul 11; Vol. 16 (14). Date of Electronic Publication: 2024 Jul 11.
Publication Type: Journal Article
Journal Info: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39061152
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: A Novel Prognostic Indicator for Immunotherapy Response: Lymphocyte-to-Albumin (LA) Ratio Predicts Survival in Metastatic NSCLC Patients.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Yildirim+S%22">Yildirim S</searchLink>; Department of Medical Oncology, Kartal Dr. Lütfi Kirdar City Hospital, Health Science University, Istanbul 34865, Turkey.<br /><searchLink fieldCode="AU" term="%22Dogan+A%22">Dogan A</searchLink>; Department of Medical Oncology, Kartal Dr. Lütfi Kirdar City Hospital, Health Science University, Istanbul 34865, Turkey.<br /><searchLink fieldCode="AU" term="%22Akdag+G%22">Akdag G</searchLink>; Department of Medical Oncology, Kartal Dr. Lütfi Kirdar City Hospital, Health Science University, Istanbul 34865, Turkey.<br /><searchLink fieldCode="AU" term="%22Cavdar+E%22">Cavdar E</searchLink>; Department of Medical Oncology, Faculty of Medicine, Tekirdag Namik Kemal University, Tekirdağ 59030, Turkey.<br /><searchLink fieldCode="AU" term="%22Kinikoglu+O%22">Kinikoglu O</searchLink>; Department of Medical Oncology, Kartal Dr. Lütfi Kirdar City Hospital, Health Science University, Istanbul 34865, Turkey.<br /><searchLink fieldCode="AU" term="%22Oksuz+S%22">Oksuz S</searchLink>; Department of Medical Oncology, Kartal Dr. Lütfi Kirdar City Hospital, Health Science University, Istanbul 34865, Turkey.<br /><searchLink fieldCode="AU" term="%22Yildiz+HS%22">Yildiz HS</searchLink>; Department of Medical Oncology, Kartal Dr. Lütfi Kirdar City Hospital, Health Science University, Istanbul 34865, Turkey.<br /><searchLink fieldCode="AU" term="%22Kucukoz+Uzun+A%22">Kucukoz Uzun A</searchLink>; Department of Nuclear Medicine, Kartal Dr. Lütfi Kirdar City Hospital, Health Science University, Istanbul 34865, Turkey.<br /><searchLink fieldCode="AU" term="%22Isik+D%22">Isik D</searchLink>; Department of Medical Oncology, Kartal Dr. Lütfi Kirdar City Hospital, Health Science University, Istanbul 34865, Turkey.<br /><searchLink fieldCode="AU" term="%22Surmeli+H%22">Surmeli H</searchLink>; Department of Medical Oncology, Kartal Dr. Lütfi Kirdar City Hospital, Health Science University, Istanbul 34865, Turkey.<br /><searchLink fieldCode="AU" term="%22Basoglu+T%22">Basoglu T</searchLink>; Department of Medical Oncology, Kartal Dr. Lütfi Kirdar City Hospital, Health Science University, Istanbul 34865, Turkey.<br /><searchLink fieldCode="AU" term="%22Sever+ON%22">Sever ON</searchLink>; Department of Medical Oncology, Kartal Dr. Lütfi Kirdar City Hospital, Health Science University, Istanbul 34865, Turkey.<br /><searchLink fieldCode="AU" term="%22Odabas+H%22">Odabas H</searchLink>; Department of Medical Oncology, Kartal Dr. Lütfi Kirdar City Hospital, Health Science University, Istanbul 34865, Turkey.<br /><searchLink fieldCode="AU" term="%22Yildirim+ME%22">Yildirim ME</searchLink>; Department of Medical Oncology, Kartal Dr. Lütfi Kirdar City Hospital, Health Science University, Istanbul 34865, Turkey.<br /><searchLink fieldCode="AU" term="%22Turan+N%22">Turan N</searchLink>; Department of Medical Oncology, Kartal Dr. Lütfi Kirdar City Hospital, Health Science University, Istanbul 34865, Turkey.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101526829%22">Cancers</searchLink> [Cancers (Basel)] 2024 Jul 11; Vol. 16 (14). <i>Date of Electronic Publication: </i>2024 Jul 11.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22MDPI%22">MDPI </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101526829 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>2072-6694 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220726694%22">20726694 </searchLink><i>NLM ISO Abbreviation: </i>Cancers (Basel) <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39061152
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3390/cancers16142512
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: A Novel Prognostic Indicator for Immunotherapy Response: Lymphocyte-to-Albumin (LA) Ratio Predicts Survival in Metastatic NSCLC Patients.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Yildirim S
      – PersonEntity:
          Name:
            NameFull: Dogan A
      – PersonEntity:
          Name:
            NameFull: Akdag G
      – PersonEntity:
          Name:
            NameFull: Cavdar E
      – PersonEntity:
          Name:
            NameFull: Kinikoglu O
      – PersonEntity:
          Name:
            NameFull: Oksuz S
      – PersonEntity:
          Name:
            NameFull: Yildiz HS
      – PersonEntity:
          Name:
            NameFull: Kucukoz Uzun A
      – PersonEntity:
          Name:
            NameFull: Isik D
      – PersonEntity:
          Name:
            NameFull: Surmeli H
      – PersonEntity:
          Name:
            NameFull: Basoglu T
      – PersonEntity:
          Name:
            NameFull: Sever ON
      – PersonEntity:
          Name:
            NameFull: Odabas H
      – PersonEntity:
          Name:
            NameFull: Yildirim ME
      – PersonEntity:
          Name:
            NameFull: Turan N
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 11
              M: 07
              Text: 2024 Jul 11
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-print
              Value: 2072-6694
          Numbering:
            – Type: volume
              Value: 16
            – Type: issue
              Value: 14
          Titles:
            – TitleFull: Cancers
              Type: main
ResultId 1